Clinical Trials Directory

Trials / Completed

CompletedNCT04831073

European Registry of Type A Aortic Dissection

Status
Completed
Phase
Study type
Observational
Enrollment
3,902 (actual)
Sponsor
Helsinki University Central Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Acute Stanford type A aortic dissection (TAAD) is a life-threatening condition. Surgery is usually performed as a salvage procedure and is associated with significant postoperative early mortality and morbidity. Understanding the patient's conditions and treatment strategies which are associated with these adverse events is essential for an appropriate management of acute TAAD.

Detailed description

Twenty centers from eight European centers of cardiac surgery have collaborated to create a multicentre observational registry (ERTAAD), which will enroll consecutive patients who underwent surgery for acute TAAD from January 2005 to March 2021. The investigators will compare patient's comorbidities, condition at referral, surgical strategies and perioperative treatments in patients with and without early and late adverse events. The primary clinical outcome will be in-hospital mortality, late mortality and reoperations on the aorta. Secondary outcomes will be stroke, acute kidney injury, surgical site infection, reoperation for bleeding, transfusion of blood products and length of stay in the intensive care unit.

Conditions

Interventions

TypeNameDescription
PROCEDURESurgery on the ascending aorta with or without repair of the aortic root and/or aortic archSurgical repair of the ascending aorta with or without surgical repair of the aortic root and/or aortic arch

Timeline

Start date
2023-02-28
Primary completion
2024-12-06
Completion
2024-12-06
First posted
2021-04-05
Last updated
2024-12-11

Locations

20 sites across 8 countries: Belgium, Czechia, Finland, France, Germany, Italy, Spain, United Kingdom

Source: ClinicalTrials.gov record NCT04831073. Inclusion in this directory is not an endorsement.